Insider · CIK 0001042021

JONAS JEFFREY M

Reports to the SEC for 6 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001042021

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-27	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+21.1K sh	—	—	21,110
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,500 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,246 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,920 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,200 sh	—	—	0
2026-02-09	GBIOGeneration Bio Co. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2025-10-29	CMPSCOMPASS Pathways plc · Share Option (Right to Buy)A Award	Director	AAward	+52K sh	—	—	52,000
2025-06-04	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2024-06-06	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2024-03-18	Karuna Therapeutics, Inc.Option (right to buyD Disposition to Issuer	Director	DDisposition to Issuer	−16.3K sh	$314.00	−$5.1M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	$201.99	−$1.72M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	$227.04	−$1.14M	0
2024-03-18	Karuna Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−990 sh	$330.00	−$327K	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buyD Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	$232.41	−$2.91M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.9K sh	$322.73	−$6.42M	0
2024-03-18	Karuna Therapeutics, Inc.Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,904 sh	$92.30	−$176K	0
2023-11-28	Sage Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	131,981
2023-11-28	Sage Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−3,935 sh	$19.27	−$75.8K	128,046
2023-09-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−4,387 sh	$187.26	−$822K	9,812
2023-09-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−600 sh	$186.34	−$112K	14,199
2023-09-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−399 sh	$188.98	−$75.4K	990
2023-09-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−8,423 sh	$188.34	−$1.59M	1,389
2023-09-01	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.8K sh	—	—	19,893
2023-09-01	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.8K sh	$7.27	+$100K	14,799
2023-08-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−600 sh	$198.41	−$119K	990
2023-08-01	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.8K sh	$7.27	+$100K	14,800
2023-08-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−6,301 sh	$195.61	−$1.23M	5,100
2023-08-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−3,110 sh	$196.59	−$611K	1,990
2023-08-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$197.66	−$79.1K	1,590
2023-08-01	Karuna Therapeutics, Inc.S Sale	Director	SSale	−3,399 sh	$194.78	−$662K	11,401
2023-08-01	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.8K sh	—	—	33,702
2023-07-03	Karuna Therapeutics, Inc.Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−13.8K sh	—	—	47,512
2023-07-03	Karuna Therapeutics, Inc.S Sale	Director	SSale	−234 sh	$214.61	−$50.2K	14,566
2023-07-03	Karuna Therapeutics, Inc.S Sale	Director	SSale	−3,201 sh	$216.78	−$694K	3,399
2023-07-03	Karuna Therapeutics, Inc.S Sale	Director	SSale	−2,409 sh	$217.82	−$525K	990
2023-07-03	Karuna Therapeutics, Inc.S Sale	Director	SSale	−7,966 sh	$215.91	−$1.72M	6,600
2023-07-03	Karuna Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.8K sh	$7.27	+$100K	14,800
2023-06-20	Karuna Therapeutics, Inc.Option (right to buy)A Award	Director	AAward	+1,904 sh	—	—	1,904
2023-06-20	Karuna Therapeutics, Inc.A Award	Director	AAward	+990 sh	—	—	990
2023-06-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-06-08	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-02-10	Sage Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.6K sh	$0.45	+$5,239.35	133,624
2023-02-10	Sage Therapeutics, Inc.Stock Options (Right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.6K sh	—	—	0
2023-02-10	Sage Therapeutics, Inc.S Sale	Director	SSale	−3,838 sh	$44.90	−$172K	121,981
2023-02-10	Sage Therapeutics, Inc.S Sale	Director	SSale	−7,805 sh	$44.47	−$347K	125,819
2023-02-03	Sage Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−1,427 sh	$44.16	−$63K	121,981
2023-02-03	Sage Therapeutics, Inc.A Award	Director	AAward	+5,100 sh	—	—	123,408

Recent filings

Accepted (ET)
May 294
JONAS JEFFREY M0001042021-26-000002
SEC(opens sec.gov)
Feb 94
JONAS JEFFREY M0001104659-26-012191
SEC(opens sec.gov)
Oct 314
JONAS JEFFREY M0001042021-25-000005
SEC(opens sec.gov)
Jun 64
JONAS JEFFREY M0001415889-25-015961
SEC(opens sec.gov)
Jun 114
JONAS JEFFREY M0001562180-24-004953
SEC(opens sec.gov)
Jun 104
JONAS JEFFREY M0001415889-24-016183
SEC(opens sec.gov)
Mar 184
JONAS JEFFREY M0001140361-24-013926
SEC(opens sec.gov)
Nov 304
JONAS JEFFREY M0001562180-23-007980
SEC(opens sec.gov)

Companies

Address

C/O COMPASS PATHWAYS PLC 33 BROADWICK STREET

LONDON, W1F 0DQ